COGNITION THERAPEUTICS
CGTX Insider Trades:
all
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2025-05-01
2025-05-02
DOYLE JOHN BRENDAN
Chief Financial Officer
F - Tax
Common Stock
-9,692
$0.00
1
$38.22M
2025-02-15
2025-02-18
CAGGIANO ANTHONY
Chief Medical Officer
F - Tax
Common Stock
-5,296
$1.00
-5,296
1
$38.22M
2025-02-15
2025-02-18
DOYLE JOHN BRENDAN
Chief Financial Officer
F - Tax
Common Stock
-1,723
$1.00
-1,723
1
$38.22M
2025-02-04
2025-02-04
DOYLE JOHN BRENDAN
Chief Financial Officer
A - Grant
Common Stock
295K
$0.00
1
$38.22M
2025-02-03
2025-02-04
CAGGIANO ANTHONY
Chief Medical Officer
F - Tax
Common Stock
-12,779
$1.00
-12,779
1
$38.22M
2025-01-31
2025-02-04
RICCIARDI LISA
CEO & President
P - Purchase
Common Stock
38,851
$1.00
38,851
1
$38.22M
2024-05-01
2024-05-03
DOYLE JOHN BRENDAN
Chief Financial Officer
F - Tax
Common Stock
-8,699
$2.00
-17,398
1
$38.22M
2024-03-14
2024-03-14
RICCIARDI LISA
CEO & President
P - Purchase
Common Stock
5,700
$2.00
11,400
1
$38.22M
2024-02-15
2024-02-20
CAGGIANO ANTHONY
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
60,000
$0.00
1
$38.22M
2024-02-15
2024-02-20
CAGGIANO ANTHONY
Chief Medical Officer
A - Grant
Common Stock
60,000
$0.00
1
$38.22M
2024-02-15
2024-02-20
DOYLE JOHN BRENDAN
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
20,000
$0.00
1
$38.22M
2024-02-15
2024-02-20
DOYLE JOHN BRENDAN
Chief Financial Officer
A - Grant
Common Stock
20,000
$0.00
1
$38.22M
2024-02-15
2024-02-20
RICCIARDI LISA
CEO & President
A - Grant
Stock Option (Right to Buy)
75,000
$0.00
1
$38.22M
2024-02-03
2024-02-09
CAGGIANO ANTHONY
Chief Medical Officer
F - Tax
Common Stock
-12,777
$2.00
-25,554
1
$38.22M
2023-05-01
2023-05-03
DOYLE JOHN BRENDAN
Chief Financial Officer
A - Grant
Stock Option (right to buy)
110K
$0.00
1
$38.22M
2023-05-01
2023-05-03
DOYLE JOHN BRENDAN
Chief Financial Officer
A - Grant
Common Stock
110K
$0.00
1
$38.22M
2023-02-03
2023-02-07
CAGGIANO ANTHONY
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
94,406
$0.00
1
$38.22M
2023-02-03
2023-02-07
CAGGIANO ANTHONY
Chief Medical Officer
A - Grant
Common Stock
94,406
$0.00
1
$38.22M
2023-02-03
2023-02-07
RICCIARDI LISA
CEO & President
A - Grant
Stock Option (Right to Buy)
214K
$0.00
1
$38.22M
2022-11-15
2022-11-16
RICCIARDI LISA
CEO & President
P - Purchase
Common Stock
12,000
$1.00
12,000
1
$38.22M
2022-09-27
2022-09-29
GOLDEN SEEDS COGNITION THERAPEUTICS LLC
J - Other
Common Stock
-2.49M
$0.00
1
$38.22M
2022-06-10
2022-06-23
RICCIARDI LISA
CEO & President
A - Grant
Stock Option (Right to Buy)
150K
$0.00
1
$38.22M
2022-06-10
2022-06-13
RICCIARDI LISA
CEO & President
A - Grant
Stock Option (right to buy)
150K
$0.00
1
$38.22M
2022-03-23
2022-03-25
CAGGIANO ANTHONY
Chief Medical Officer
A - Grant
Stock Option (right to buy)
25,000
$0.00
1
$38.22M
2022-03-23
2022-03-25
O'BRIEN JAMES MICHAEL
Chief Financial Officer
A - Grant
Stock Option (right to buy)
50,000
$0.00
1
$38.22M
2021-11-01
2021-11-10
CAGGIANO ANTHONY
Chief Medical Officer
A - Grant
Stock Option (right to buy)
162K
$0.00
1
$38.22M
2021-10-13
2021-10-15
OGDEN CAP ASSOCIATES, LLC
X - Exercise
Warrant (right to buy)
-27,471
$0.00
1
$38.22M
2021-10-13
2021-10-15
GOLDEN SEEDS COGNITION THERAPEUTICS LLC
S - Sale
Common Stock
-33
$12.00
-396
1
$38.22M
2021-10-13
2021-10-15
BREEDLOVE MARK
C - Conversion
Series A-1 Convertible Preferred Stock
-145K
$0.00
1
$38.22M
2021-10-13
2021-10-15
BREEDLOVE MARK
C - Conversion
Series A-2 Convertible Preferred Stock
-119K
$0.00
1
$38.22M
2021-10-13
2021-10-15
BREEDLOVE MARK
C - Conversion
Series B Convertible Preferred Stock
-826K
$0.00
1
$38.22M
2021-10-13
2021-10-15
BREEDLOVE MARK
C - Conversion
Series B-1 Convertible Preferred Stock
-302K
$0.00
1
$38.22M
2021-10-13
2021-10-15
FLETCHER AARON G.L.
C - Conversion
Series B Convertible Preferred Stock
-6.75M
$0.00
3
$38.22M
2021-10-13
2021-10-15
FLETCHER AARON G.L.
C - Conversion
Series B-1 Convertible Preferred Stock
-4.51M
$0.00
7
$38.22M
2021-10-13
2021-10-15
FLETCHER AARON G.L.
C - Conversion
Simple Agreement for Future Equity
-208K
$0.00
3
$38.22M
2021-10-13
2021-10-15
GOLDEN SEEDS COGNITION THERAPEUTICS LLC
C - Conversion
Series A-1 Convertible Preferred Stock
-884K
$0.00
1
$38.22M
2021-10-13
2021-10-15
GOLDEN SEEDS COGNITION THERAPEUTICS LLC
C - Conversion
Series A-2 Convertible Preferred Stock
-542K
$0.00
1
$38.22M
2021-10-13
2021-10-15
GOLDEN SEEDS COGNITION THERAPEUTICS LLC
C - Conversion
Series B Convertible Preferred Stock
-4.00M
$0.00
1
$38.22M
2021-10-13
2021-10-15
GOLDEN SEEDS COGNITION THERAPEUTICS LLC
C - Conversion
Series B-1 Convertible Preferred Stock
-1.57M
$0.00
1
$38.22M
2021-10-13
2021-10-15
GOLDEN SEEDS COGNITION THERAPEUTICS LLC
C - Conversion
Simple Agreement for Future Equity
-312K
$0.00
1
$38.22M
2021-10-13
2021-10-15
GOLDEN SEEDS COGNITION THERAPEUTICS LLC
C - Conversion
Common Stock
2.48M
5
$38.22M
2021-10-13
2021-10-15
OGDEN CAP ASSOCIATES, LLC
C - Conversion
Series A Convertible Preferred Stock
-1.32M
$0.00
1
$38.22M
2021-10-13
2021-10-15
OGDEN CAP ASSOCIATES, LLC
C - Conversion
Series A-1 Convertible Preferred Stock
-333K
$0.00
1
$38.22M
2021-10-13
2021-10-15
BIOS MEMORY SPV I, LP
C - Conversion
Series B Convertible Preferred Stock
-6.75M
$0.00
3
$38.22M
2021-10-13
2021-10-15
BIOS MEMORY SPV I, LP
C - Conversion
Series B-1 Convertible Preferred Stock
-4.51M
$0.00
7
$38.22M
2021-10-13
2021-10-15
OGDEN CAP ASSOCIATES, LLC
C - Conversion
Series A-2 Convertible Preferred Stock
-882K
$0.00
1
$38.22M
2021-10-13
2021-10-15
OGDEN CAP ASSOCIATES, LLC
C - Conversion
Series B Convertible Preferred Stock
-4.09M
$0.00
1
$38.22M
2021-10-13
2021-10-15
OGDEN CAP ASSOCIATES, LLC
C - Conversion
Series B-1 Convertible Preferred Stock
-439K
$0.00
1
$38.22M
2021-10-13
2021-10-15
GOLDEN SEEDS COGNITION THERAPEUTICS LLC
X - Exercise
Warrant (right to buy)
-12,276
$0.00
1
$38.22M
2021-10-13
2021-10-15
GOLDEN SEEDS COGNITION THERAPEUTICS LLC
X - Exercise
Common Stock
12,276
$0.00
1
$38.22M
2021-10-13
2021-10-15
BIOS MEMORY SPV I, LP
C - Conversion
Simple Agreement for Future Equity
-208K
$0.00
3
$38.22M
2021-10-13
2021-10-14
O'BRIEN JAMES MICHAEL
Chief Financial Officer
P - Purchase
Common Stock
5,000
$12.00
60,000
1
$38.22M
2021-10-13
2021-10-14
RICCIARDI LISA
CEO & President
P - Purchase
Common Stock
12,500
$12.00
150K
1
$38.22M
2021-10-07
2021-10-12
O'BRIEN JAMES MICHAEL
Chief Financial Officer
A - Grant
Stock Option (right to buy)
54,457
$0.00
1
$38.22M
2021-10-07
2021-10-12
RICCIARDI LISA
CEO & President
A - Grant
Stock Option (right to buy)
1.13M
$0.00
3
$38.22M